Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new PubMed publication entry for Shitara et al. on first-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. The citation shows Nat Med 2026 Jun;32(6):2182-2190 with an Epub date of 2026 Mar 16, replacing the earlier Online ahead of print note.
    Difference
    0.0%
    Check dated 2026-07-15T13:23:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, replacing the previous v3.6.0 on the page. This indicates a new site revision without altering study details.
    Difference
    0.0%
    Check dated 2026-07-01T10:17:53.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The study milestone dates were updated to Primary Completion: 2026-12-31 and Study Completion: 2027-11-30, with the last update posted on 2026-06-18, reflecting a refreshed timeline.
    Difference
    0.2%
    Check dated 2026-06-24T05:34:48.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Recruitment messaging now shows 'No longer looking for participants', the treatment label is standardized to 'Intervention/Treatment' (replacing 'Intervention / Treatment'), several help/navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision badge updates from v3.5.4 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-09T20:12:59.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and the previous revision v3.5.3 was removed, indicating a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-05-19T09:56:59.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A new bibliographic citation to a 2025 biomarker-driven study on metastatic gastric/GEJ cancer was added to Publications, expanding the referenced literature for the trial page.
    Difference
    0.0%
    Check dated 2026-05-12T08:20:25.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.